@article{article, title  = {{P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{https://doi.org/10.1038/s43018-022-00394-x }},

 year = {{2022}},

 month = {{6}},

 author = {{Lin KH and Rutter JC and Xie A and Killarney ST and Vaganay C and Benaksas C and Ling F and Sodaro G and Meslin P-A and Bassil CF and Fenouille N et al}},

 doi = {{10.1038/s43018-022-00394-x}},

 volume = {{3}},

 journal = {{Nature Cancer}},

 issue = {{7}},

 pages = {{837-851}},

 note = {{Accessed on 2026/03/17}}}